Physicians typically treat spinal stenosis with a direct decompression to remove either soft tissue or bone causing the central canal to narrow. As a result, the nerves have more space to function and there is less pressure and swelling. The intended clinical effect of spinal stenosis treatment is pain and symptom relief, allowing patients to return to normal activity.
Surgeons can either achieve the intended clinical effect by stabilization with fusion or stabilization with motion preservation. The colfex Interlaminar Stabilization Technology promotes natural motion in the spine at the area of decompression and adjacent segments while maintaining foraminal height so nerves can exit the spine freely without being compressed.
This outpatient procedure can be performed in ambulatory surgery centers, where infection rates are lower than the inpatient hospital setting. It also costs less to perform cases in ASCs, generating a cost-savings for the healthcare system.
In a coflex IDE study, it was found that coflex and fusion control showed comparative effectiveness. coflex maintained foraminal height at 24 months, according to the study, and coflex patients outperformed fusion patients in Oswestry Disability Index over the course of two years.
Paradigm Spine will present a webinar on March 26 at 2:15pm EST, hosted by Becker’s Healthcare called “Driving Value and Outcomes in the Treatment of Lumbar Spinal Stenosis” And featuring James Chappuis, MD, of Spine Care Atlanta. Hal Mathews, MD, MBA will moderate the discussion.
The webinar will include a discussion on how to define value in the treatment of lumbar spinal stenosis with all stakeholders in mind and will also address the cost drivers associated with the coflex device.
More Articles on Spine:
Anterior Spine Surgery for Disc Herniation at C7-T1: Outcomes Analysis
Orthopedic, Neurosurgeon Roles: Medical Teaching, Administrative & Research
Growing Patient Volume in 2014 & Beyond: 4 Spine Surgeon Initiatives
